Cancer drug company Tesaro shares rise 39% following report that it will explore sale

Health, Fitness & Food

Tesaro shares soared 39 percent Friday upon a Bloomberg report that the pharmaceutical company will explore the opportunity of a sale.

This comes exactly one week after Tesaro fell more than 20 percent during after-hours trading after the release of drug trial results. A spokesperson declined to comment.

This story is developing. Please check back for updates.

Products You May Like

Leave a Reply

Your email address will not be published.